Transforming demand generation, boosting responses up to sixfold
Transforming demand generation, boosting responses up to sixfold
IBM Unica empowers customers, accelerates key marketing processes, improves marketing performance
2019 MRD Conference
I was honored to participate in the 2019 MRD Meeting in NYC hosted by the the MMRF and Memorial Sloan Kettering Cancer Center. 2019 MRD Meeting in NYC Patient Panel October 2 marked the 6th consecutive year of the Advances in Minimal Residual Disease Testing (MRD) in Myeloma roundtable meeting, a collaborative effort between Memorial Sloan Kettering Cancer Center and the MMRF. This meeting is a yearly opportunity for the myeloma community to come together to discuss the use of MRD testing in clinical practice and the progress toward its acceptance (by FDA) as a surrogate clinical endpoint for myeloma clinical trials. Attendees are a cross-section of the myeloma community, including leading myeloma physicians, pharmaceutical company representatives, scientists, and this year, for the first time, patient representatives. All of them came prepared to debate a number of topics related to MRD measurement in myeloma. In each session, audience opinions were assess...
Comments
Post a Comment